Literature DB >> 10390734

The impact of a brief coping skills intervention on adherence to breast self-examination among first-degree relatives of newly diagnosed breast cancer patients.

J Audrain1, B Rimer, D Cella, M Stefanek, J Garber, M Pennanen, K Helzlsouer, V Vogel, T H Lin, C Lerman.   

Abstract

The present investigation sought to determine (1) the impact of a single session stress management/coping intervention (problem-solving training; PST) versus a general health counseling (GHC) control condition on breast self-examination (BSE) adherence among relatives of newly diagnosed breast cancer patients, and (2) whether women with heightened perceived risk of breast cancer and/or cancer specific distress at baseline were more likely to improve their BSE adherence following PST. The participants were 510 women age 20-75 who had at least one first-degree relative with breast cancer. All of the participants completed a baseline telephone interview, an intervention (PST versus GHC), and a 3-month follow-up telephone interview. The results revealed a 36% overall improvement in BSE adherence, with no significant between-group difference in improvement (chi 2 = 0.03, p = 0.87). The logistic regression analysis of improvement in BSE adherence revealed a statistically significant cancer-specific distress by treatment interaction (p = 0.04). Among women who received PST, those with high levels of cancer-specific distress were two times more likely to improve in BSE adherence than women low in cancer-specific distress. There was no effect of cancer-specific distress in the control condition. These results suggest that women with a family history of breast cancer who have high levels of distress may be most likely to benefit from behavioral coping skills intervention to promote adherence to breast cancer screening.

Entities:  

Mesh:

Year:  1999        PMID: 10390734     DOI: 10.1002/(SICI)1099-1611(199905/06)8:3<220::AID-PON370>3.0.CO;2-C

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  7 in total

1.  Incorporating a Psychological Counselor in a Cancer Risk Assessment Program: Necessity, Acceptability, and Potential Roles.

Authors:  Alicia K Matthews; Dana L Brandenburg; Shelly Cummings; Olufunmilayo I Olopade
Journal:  J Genet Couns       Date:  2002-02       Impact factor: 2.537

2.  Racial differences in quality of life following prostate cancer diagnosis.

Authors:  Chanita H Halbert; James Coyne; Benita Weathers; Brandon Mahler; Ernestine Delmoor; David Vaughn; S Bruce Malkowicz; David Lee; Andrea Troxel
Journal:  Urology       Date:  2010-03-07       Impact factor: 2.649

3.  Physical activity in first-degree relatives of breast cancer patients.

Authors:  J Audrain; M Schwartz; J Herrera; P Goldman; A Bush
Journal:  J Behav Med       Date:  2001-12

4.  "I wouldn't classify myself as a patient": the importance of a "well-being" environment for individuals receiving counseling about familial cancer risk.

Authors:  Ceri Phelps; Debra Horrigan; Liwsi Kim Protheroe; Janina Hopkin; Wendy Jones; Alexandra Murray
Journal:  J Genet Couns       Date:  2008-07-08       Impact factor: 2.537

Review 5.  Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis.

Authors:  Dejana Braithwaite; Jon Emery; Fiona Walter; A Toby Prevost; Stephen Sutton
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

6.  A randomised controlled trial of a psychoeducational intervention for women at increased risk of breast cancer.

Authors:  S Appleton; M Watson; R Rush; S Garcia-Minaur; M Porteous; J Campbell; E Anderson; A Cull
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

7.  A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes.

Authors:  P Hopwood; D Wonderling; M Watson; A Cull; F Douglas; T Cole; D Eccles; J Gray; V Murday; M Steel; J Burn; K McPherson
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.